Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
An orally available tyrosine kinase inhibitor that works by blocking the BCR-ABL1 fusion protein, Scemblix received accelerated approval in November 2021 for patients with Philadelphia chromosome-positive, chronic phase CML and full approval for patients in this population whose cancer carries the T315I mutation
Alcohol can worsen nausea, reflux, dehydration, dizziness, blood sugar swings, and poor food tolerance
Togo, A
Anecdotal reports commonly mention improved sleep onset, better sleep quality, and more refreshed waking
Bottom: volcano plot showing relative fold change (log 2 ) in whole cell metabolite abundance versus log 10 (P value) from ER-tag HEK293T cells treated with antimycin compared to untreated
US$ 28.02
US$ 28.84
US$ 20.12
